Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
Hims & Hers Health (HIMS) Stock Price & Analysis
1,227 Followers
HIMS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.65 - $17.16
Previous Close$11.9
Volume4.83M
Average Volume (3M)5.10M
Market Cap
$2.55B
Enterprise Value$2.34B
Total Cash (Recent Filing)$212.50M
Total Debt (Recent Filing)$4.70M
Price to Earnings (P/E)-105.0
Beta1.70
Next Earnings
May 06, 2024EPS Estimate
<$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding214,250,313
10 Day Avg. Volume4,463,407
30 Day Avg. Volume5,103,461
Standard Deviation0.19
R-Squared0.07
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)11.88
Price to Sales (P/S)4.65
Price to Cash Flow (P/CF)29.00
P/FCF Ratio14.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.95
Enterprise Value/Gross Profit5.73
Enterprise Value/Ebitda255.90
Forecast
1Y Price Target
$15.25Price Target Upside28.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Hims & Hers Health News
PremiumCompany Announcements
Hims & Hers Health Welcomes New Independent Director
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company achieved its 2025 revenue/EBITDA targets ahead of schedule, indicating strong execution and financial performance.
Growth StrategyHigh retention rates and new initiatives in weight management and mental health are expected to drive revenue growth.
Market PositionHIMS is well-positioned to capitalize on significant opportunities in the dynamic healthcare market and evolving patient and consumer needs.
Bears Say
User EngagementMarch witnessed the first month-over-month decline in Monthly Active Users since December 2021.
Valuation ConcernsHIMS trades at a higher multiple than most peers, reflecting revenue and EBITDA growth trajectory in the valuation.
Website TrafficMarch also presenting the first year-over-year decline in web visits.
---
Ownership Overview
40.14% Insiders
12.83% Mutual Funds
11.38% Other Institutional Investors
35.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Hims & Hers Health
Desktop Users
Mobile Users
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $5.65 and its highest was $17.16 in the past 12 months.
What is Hims & Hers Health’s market cap?
Currently, no data Available
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is May 06, 2024 which is in 12 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Feb 26, 2024. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.022 by $0.032.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is <$0.01.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 205,872,700 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.022. Following the earnings report the stock price went up 31.024%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Among the largest hedge funds holding Hims & Hers Health’s share is Royce & Associates LLC. It holds Hims & Hers Health’s shares valued at 2M.
---
Hims & Hers Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.25 (28.15% Upside)
$15.25 (28.15% Upside)
Blogger Sentiment
Bullish
HIMS Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 124.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.34%
12-Months-Change
Fundamentals
Return on Equity
-7.18%
Trailing 12-Months
Asset Growth
20.43%
Trailing 12-Months
Company Description
Hims & Hers Health
Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.
---
HIMS Company Deck
---
HIMS Earnings Call
Q4 2024
0:00 / 0:00
---
HIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
---
HIMS Stock 12 Months Forecast
Average Price Target
$15.25
▲(28.15% Upside)
Technical Analysis
Perrigo Company
―
Walgreens Boots Alliance
―
Teva Pharmaceutical
―
Amneal Pharmaceuticals
―
Best Analysts Covering HIMS
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+50.80%
reiterated a buy rating 2 months ago
Copying Jack Wallace's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +50.80% per trade.
---